Publication: Clinical Impact of Patient-Prosthesis Mismatch After Aortic Valve Replacement With a Mechanical or Biological Prosthesis
| dc.contributor.author | Matkovic, Milos (57113361300) | |
| dc.contributor.author | Aleksic, Nemanja (57209310510) | |
| dc.contributor.author | Bilbija, Ilija (57113576000) | |
| dc.contributor.author | Antic, Ana (57224966433) | |
| dc.contributor.author | Lazovic, Jelena Milin (6507693272) | |
| dc.contributor.author | Cubrilo, Marko (57209307258) | |
| dc.contributor.author | Milojevic, Aleksandar (57219864196) | |
| dc.contributor.author | Zivkovic, Igor (57192104502) | |
| dc.contributor.author | Putnik, Svetozar (16550571800) | |
| dc.date.accessioned | 2025-06-12T12:08:25Z | |
| dc.date.available | 2025-06-12T12:08:25Z | |
| dc.date.issued | 2023 | |
| dc.description.abstract | Background: Patient-prosthesis mismatch (PPM) may impair functional capacity and survival after aortic valve replacement. This study aimed to investigate the impact of PPM on long-term survival and quality of life after mechanical and biological aortic valve replacement. Methods: This study included 595 consecutive patients who had undergone isolated aortic valve replace-ment. Patients were divided into 2 groups according to prosthesis type. The baseline and operative charac-teristics, survival rates, complications, and quality of life of the groups with and without PPM were compared for up to 6 years. The PPM calculation was performed using the effective orifice area value provided by the manufacturer divided by the patient’s body surface area. Results: The moderate to severe PPM rates were 69.8% and 3.7% after biological and mechanical prosthesis implantation, respectively. Mean survival for patients in the biological group who had PPM was statistically significantly shorter (50.2 months [95% CI, 45.2-55.3]) than for patients in the biological group without PPM (60.1 months [95% CI, 55.7-64.4]; P = .04). In the mechanical prosthesis group, there was no difference in mean survival between the subgroup with PPM (66.6 months [95% CI, 58.3-74.9]) and the subgroup without PPM (64.9 months [95% CI, 62.6-67.2]; P = .50). A quality-of-life questionnaire’s scores did not differ between the groups. Conclusion: Mismatch is common after biological valve implantation and statistically significantly affects long-term survival and quality of life. If the risk of PPM after implantation of a biological prosthesis is sus-pected, adopting strategies to avoid PPM at the time of surgery is warranted. © 2023, Texas Heart Institute. All rights reserved. | |
| dc.identifier.uri | https://doi.org/10.14503/THIJ-22-8048 | |
| dc.identifier.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85175266601&doi=10.14503%2fTHIJ-22-8048&partnerID=40&md5=40a9567ce842b9be9ae4a88fc225e753 | |
| dc.identifier.uri | https://remedy.med.bg.ac.rs/handle/123456789/2544 | |
| dc.subject | aortic valve disease | |
| dc.subject | bioprosthesis | |
| dc.subject | heart valve prosthesis implantation | |
| dc.subject | Patient outcome assessment | |
| dc.subject | quality of life | |
| dc.title | Clinical Impact of Patient-Prosthesis Mismatch After Aortic Valve Replacement With a Mechanical or Biological Prosthesis | |
| dspace.entity.type | Publication |
